HealthTab(TM) to Power NHS Pilot

Executive Summary

• Avricore Health announced the launch of a new pilot with Barts Health NHS Trust, UCL Partners and the British Heart Foundation to deliver inclisiran cholesterol‑lowering injections through community pharmacies using its HealthTab™ platform.
• The pilot integrates HealthTab™ with the Ortus‑iHealth platform, enabling real‑time data flow from pharmacy point‑of‑care testing into hospital clinical systems and NHS digital pathways.
• Supported by a £198,000 BHF grant, the initiative expands HealthTab’s addressable market into secondary‑prevention cardiovascular care and positions the company as a core technology partner for NHS pharmacy‑based chronic‑condition management.

Key Details

• Pilot Scope: Deployment of HealthTab™ in community pharmacies participating in Barts Health NHS Trust’s ELoPE‑CVD programme to administer inclisiran injections, initiate therapy sooner, and provide structured follow‑up for patients with established cardiovascular disease.
• Integration Highlights:
• Direct connectivity between HealthTab™ and Ortus‑iHealth platform allows pharmacy‑generated results to flow instantly into hospital electronic health records.
• Complements existing integration with the NHS App (via Patient Knows Best) for seamless data access by clinicians and patients.
• Financial Support: £198,000 grant from the British Heart Foundation earmarked to fund pilot execution and related technology integration.
• Strategic Impact:
• Moves HealthTab™ from primary‑prevention screening into therapy‑linked workflows (inclisiran administration, monitoring).
• Strengthens Avricore’s position within UK community pharmacy networks and aligns with NHS policy to shift chronic‑condition management into pharmacies.
• Market Expansion: Enables participation in long‑term lipid‑management pathways, substantially increasing the addressable market for HealthTab™ across NHS pharmacy‑based care models.
• Quote (CEO Rodger Seccombe): “Bringing inclisiran injections into community pharmacies is an important milestone for cardiovascular care… HealthTab is enabling those same pharmacies to play a meaningful role in secondary prevention and long‑term condition management.”

Notable Quotes

“Bringing inclisartan injections into community pharmacies is an important milestone for cardiovascular care, and we’re proud that HealthTab is helping make it possible,” – Rodger Seccombe, CEO, Avricore Health.